3537

SHOEI YAKUHIN CO.,LTD.

昭栄薬品

Industry
Wholesale Trade
Market
Standard
Accounting standards
Japanese GAAP
Consolidation basis
Consolidated

Key metrics

Revenue(thousand JPY)

Mar 2021
17,032,260
Mar 2022
21,147,821
Mar 2023
24,529,038
Mar 2024
22,595,830
Mar 2025
25,012,868

Operating profit(thousand JPY)

Mar 2021
157,638
Mar 2022
302,336
Mar 2023
488,215
Mar 2024
440,316
Mar 2025
559,832

Operating profit margin(%)

Mar 2021
0.93
Mar 2022
1.43
Mar 2023
1.99
Mar 2024
1.95
Mar 2025
2.24

Profit before tax(thousand JPY)

Mar 2021
316,230
Mar 2022
844,904
Mar 2023
673,545
Mar 2024
651,730
Mar 2025
757,557

Profit(thousand JPY)

Mar 2021
237,774
Mar 2022
578,640
Mar 2023
484,559
Mar 2024
491,913
Mar 2025
527,412

Total assets(thousand JPY)

Mar 2021
14,605,801
Mar 2022
14,480,863
Mar 2023
14,798,019
Mar 2024
16,815,943
Mar 2025
17,098,397

Cash and cash equivalents(thousand JPY)

Mar 2021
1,010,940
Mar 2022
913,365
Mar 2023
1,260,944
Mar 2024
1,901,887
Mar 2025
1,587,125

Cash flows from operating activities(thousand JPY)

Mar 2021
324,817
Mar 2022
-398,371
Mar 2023
644,570
Mar 2024
818,263
Mar 2025
-171,649

Cash flows from investing activities(thousand JPY)

Mar 2021
39,014
Mar 2022
382,729
Mar 2023
-30,110
Mar 2024
-18,433
Mar 2025
-21,013

Cash flows from financing activities(thousand JPY)

Mar 2021
-77,019
Mar 2022
-62,477
Mar 2023
-269,324
Mar 2024
-172,143
Mar 2025
-129,273

Return on equity(%)

Mar 2021
3
Mar 2022
7.9
Mar 2023
6.8
Mar 2024
6.3
Mar 2025
6.2

Equity ratio(%)

Mar 2021
52.3
Mar 2022
48
Mar 2023
49.8
Mar 2024
48.4
Mar 2025
52.3

Earnings per share(JPY per share)

Mar 2021
68.47
Mar 2022
167.29
Mar 2023
141.83
Mar 2024
144.75
Mar 2025
154.78

Net assets per share(JPY per share)

Mar 2021
2,202.48
Mar 2022
2,011.64
Mar 2023
2,172.26
Mar 2024
2,392.07
Mar 2025
2,619.85

Dividend per share(JPY per share)

Mar 2021
18
Mar 2022
42
Mar 2023
36
Mar 2024
38
Mar 2025
39

Payout ratio(%)

Mar 2021
26.29
Mar 2022
25.11
Mar 2023
25.38
Mar 2024
26.25
Mar 2025
25.2

Disclaimer

The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.

The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.